Heartflow, Inc. (HTFL) stock
HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30586% above fair value
$59.92+0.82 (+1.39%)
Close on Nov 12, 2026Market cap $5.21BP/E –Yield –
Heartflow ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Heartflow's ebitda for the twelve months ending Sep 30, 2026 was -$73.60M. For fiscal 2025 it was -$58.63M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$58.63M | – |
| FY2024 | Dec 31, 2024 | -$55.86M | – |
| FY2023 | Dec 31, 2023 | -$68.17M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$12.46M | – |
| Q2 FY2026 | Jun 30, 2026 | -$16.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$28.08M | – |
| Q4 FY2025 | Dec 31, 2025 | -$16.38M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.32M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.13M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.47M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.54M | – |
See a number that looks wrong?